DrugDashboards

oxcarbazepine

oxcarbazepine · OXCARBAZEPINE 300 mg/5mL · For Suspension · Oral · Macleods Pharmaceuticals Limited

NDC 33342-0259-67 · 1 BOTTLE in 1 CARTON / 250 mL in 1 BOTTLE · ANDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for oxcarbazepine (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA207300
TE code
AB
Approval date
Jul 11, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of oxcarbazepine (For Suspension)

LabelerStrengthFirst seenLast seen
Macleods Pharmaceuticals LimitedOXCARBAZEPINE 300 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "oxcarbazepine — NDC 33342-0259-67," retrieved September 3, 2026, https://drugdashboards.com/drug/33342025967.

Free to cite with attribution — see how the data is put together.